Resolution of secondary hemophagocytic lymphohistiocytosis after treatment with the JAK1/2 inhibitor ruxolitinib

Scott R. Goldsmith, Sana Saif Ur Rehman, Cara L. Shirai, Kiran Vij, John F. DiPersio

Research output: Contribution to journalArticlepeer-review

20 Scopus citations
Original languageEnglish
Pages (from-to)4131-4135
Number of pages5
JournalBlood Advances
Issue number23
StatePublished - Dec 10 2019

Cite this